← Stocks · CRIS record
Signal record & history · Trifecta Signals
Curis has been flagged by the Trifecta screener 2 times since 2022 — every signal stayed Early. None confirmed.
Price refreshes every trading day after the close.
Full interactive chart ↗ · partner link
Daily closes · through the most recent close
Price history from Jan 2018 · Signal tracking began Jan 2022
Early basis — every figure on this page counts Early signals only. Confirmed-signal statistics (median return, +10% in 90 days, S&P 500 comparison) do not exist for CRIS and are not shown.
First signal Jan 2022 · Latest Apr 2022 · Confirmed 0 of 2 Early · Latest close in the chart data: Thu, Nov 5, 2026
The group breakdown appears once a signal confirms. CRIS has 0 confirmed signals, so there is no group breakdown to show yet — groups are assigned at confirmation, and all two of CRIS’s signals are still Early-only.
Of Curis’s two Early signals since January 2022, zero confirmed. With no confirmed signals there is no median return, no +10%-within-90-days count, and no S&P 500 comparison to report — those statistics are confirmed-only, and none is estimated from the Early signals. All two Early signals never confirmed and count in no statistic.
Every Early signal in the record, newest first. None of them confirmed.
Members see every Early signal below.
Membership unlocks the complete Early-signal timeline for CRIS and every other stock in the record — group tags, caution flags, and the full screener.
Already a member? Sign in and this page unlocks.
Curis sits in the Healthcare sector, in the Biotechnology industry. With a market value of about $1.7 million, the company falls in the small-cap group.
What can be described so far is classification: its latest signal was rated Low Quality, revenue was shrinking by about 1.7% at the time, and it sat in the large-cap group when that signal fired.
The stock closed Thursday, November 5 at $0.85, down 23.4% on the day. The last five sessions span about $0.60 to about $1.11.
